Laura Bukavina

16PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Women's studies (incl. girls' studies)Cross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 10, 2026
Hybrid grading systems improve progression risk stratification in non-invasive papillary urothelial carcinoma and support a histomorphological continuum of disease progression.

|May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma.

|Apr 29, 2026
Association Between Antibiotic Therapy and Treatment Effectiveness in Patients With Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors.

|Sep 22, 2025
Genetic susceptibility and environmental risk factors in bladder cancer: Evidence from the UK biobank.

Laura Bukavina, Ilaha Isali, Sneha Parekh

|Apr 10, 2025
Gender Disparities in Citations and Altmetric Attention Score in Oncology.

Rebecca A Campbell, Emma Helstrom, Lauren Chew

|Aug 16, 2024
Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets.

Imran Safder, Henkel Valentine, Nicole Uzzo

Pageof 3

Frequent Collaborators

5 joint publications

Philip H Abbosh

4 joint publications

Andres F Correa

4 joint publications

Elizabeth R Plimack

4 joint publications

Jason R Brown